Related Experiment Video
Updated: Jul 11, 2026

A Strategy for Sensitive, Large Scale Quantitative Metabolomics
Published on: May 27, 2014
Integration of metabolomics and genomics implicates a causality between 1398 blood metabolites and gout
Mingyuan Fan1, Zhangjun Yun2, Jiushu Yuan1
1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Introduction:
Metabolic disorders represent a hallmark feature of gout. However, evidence on the causality of blood metabolites and gout remains lacking. We performed a Mendelian randomization (MR) analysis to systematically evaluate the causality from genetically proxied 1398 blood metabolites to gout.
Method:
Genome-wide association study (GWAS) data for 1398 blood metabolites were extracted from 8299 European subjects. The discovery stage was performed using gout data from FinnGen consortium R9 to initially explore causal associations between metabolites and gout. The significant associations identified in the discovery stage were validated in the replication stage employing gout GWAS data from the IEU database. Random-effect inverse variance weighted was chosen as the main method for causality analysis, with MR-Egger, weighted median, robust adjusted profile score, and maximum likelihood as complementary analysis methods. Then, a series of sensitivity analyses were performed.
Results:
Results showed that there was a significant causal relationship between eight metabolites and gout, including 21-hydroxypregnenolone disulfate levels, carnitine levels, ethyl beta-glucopyranoside levels, gamma-glutamylglycine levels, glycine levels, glycine-to-alanine ratio, glycolithocholate sulfate levels, and propionylglycine levels. Colocalization analysis evidence strongly supported a causal relationship between 21-hydroxypregnenolone disulfate levels and carnitine levels and gout. In addition, four metabolic pathways were involved in the biological process of gout (carnitine synthesis, beta oxidation of very long-chain fatty acids, alanine metabolism, glutathione metabolism).
Conclusions:
The current study provides evidentiary support for the causal relationship between eight blood metabolites and gout and identifies four significant metabolic pathways. These findings hold the potential to inform future research, clinical interventions, and therapeutic strategies for gout.
Related Concept Videos
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenomics: Identification of New Drug Targets

